These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

222 related articles for article (PubMed ID: 12524224)

  • 21. Peroxisome proliferator-activated receptor gamma ligands, 15-deoxy-Delta12,14-prostaglandin J2, and ciglitazone, induce growth inhibition and cell cycle arrest in hepatic oval cells.
    Cheng J; Nakamura H; Imanishi H; Liu W; Morisaki T; Sugiyama T; Hada T
    Biochem Biophys Res Commun; 2004 Sep; 322(2):458-64. PubMed ID: 15325252
    [TBL] [Abstract][Full Text] [Related]  

  • 22. 15-deoxy-delta 12,14-prostaglandin J2 and laminar fluid shear stress stabilize c-IAP1 in vascular endothelial cells.
    Taba Y; Miyagi M; Miwa Y; Inoue H; Takahashi-Yanaga F; Morimoto S; Sasaguri T
    Am J Physiol Heart Circ Physiol; 2003 Jul; 285(1):H38-46. PubMed ID: 12623786
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Contrasting effects of peroxisome-proliferator-activated receptor (PPAR)gamma agonists on membrane-associated prostaglandin E2 synthase-1 in IL-1beta-stimulated rat chondrocytes: evidence for PPARgamma-independent inhibition by 15-deoxy-Delta12,14prostaglandin J2.
    Bianchi A; Moulin D; Sebillaud S; Koufany M; Galteau MM; Netter P; Terlain B; Jouzeau JY
    Arthritis Res Ther; 2005; 7(6):R1325-37. PubMed ID: 16277686
    [TBL] [Abstract][Full Text] [Related]  

  • 24. PPAR gamma ligands, 15-deoxy-delta12,14-prostaglandin J2 and rosiglitazone regulate human cultured airway smooth muscle proliferation through different mechanisms.
    Ward JE; Gould H; Harris T; Bonacci JV; Stewart AG
    Br J Pharmacol; 2004 Feb; 141(3):517-25. PubMed ID: 14718259
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Endothelial cell apoptosis induced by the peroxisome proliferator-activated receptor (PPAR) ligand 15-deoxy-Delta12, 14-prostaglandin J2.
    Bishop-Bailey D; Hla T
    J Biol Chem; 1999 Jun; 274(24):17042-8. PubMed ID: 10358055
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Inhibition of IFN-gamma-mediated inducible nitric oxide synthase induction by the peroxisome proliferator-activated receptor gamma agonist, 15-deoxy-delta 12,14-prostaglandin J2, involves inhibition of the upstream Janus kinase/STAT1 signaling pathway.
    Chen CW; Chang YH; Tsi CJ; Lin WW
    J Immunol; 2003 Jul; 171(2):979-88. PubMed ID: 12847270
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Peroxisome proliferator-activated receptor-gamma ligands inhibit nitric oxide synthesis in vascular smooth muscle cells.
    Ikeda U; Shimpo M; Murakami Y; Shimada K
    Hypertension; 2000 Jun; 35(6):1232-6. PubMed ID: 10856269
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Ligands of peroxisome proliferator-activated receptor-gamma increase the generation of vascular endothelial growth factor in vascular smooth muscle cells and in macrophages.
    Jozkowicz A; Dulak J; Piatkowska E; Placha W; Dembinska-Kiec A
    Acta Biochim Pol; 2000; 47(4):1147-57. PubMed ID: 11996104
    [TBL] [Abstract][Full Text] [Related]  

  • 29. PPAR gamma-ligands inhibit migration mediated by multiple chemoattractants in vascular smooth muscle cells.
    Goetze S; Xi XP; Kawano H; Gotlibowski T; Fleck E; Hsueh WA; Law RE
    J Cardiovasc Pharmacol; 1999 May; 33(5):798-806. PubMed ID: 10226869
    [TBL] [Abstract][Full Text] [Related]  

  • 30. 15-deoxy-Delta12,14-prostaglandin J2 (15d-PGJ2) and ciglitazone modulate Staphylococcus aureus-dependent astrocyte activation primarily through a PPAR-gamma-independent pathway.
    Phulwani NK; Feinstein DL; Gavrilyuk V; Akar C; Kielian T
    J Neurochem; 2006 Dec; 99(5):1389-1402. PubMed ID: 17074064
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Synergistic effect of peroxisome proliferator activated receptor-gamma and liver X receptor-alpha in the regulation of inflammation in macrophages.
    Piraino G; Cook JA; O'Connor M; Hake PW; Burroughs TJ; Teti D; Zingarelli B
    Shock; 2006 Aug; 26(2):146-53. PubMed ID: 16878022
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Activators of peroxisome proliferator-activated receptor-gamma (PPARgamma) inhibit inducible nitric oxide synthase expression but increase heme oxygenase-1 expression in rat glial cells.
    Kitamura Y; Kakimura J; Matsuoka Y; Nomura Y; Gebicke-Haerter PJ; Taniguchi T
    Neurosci Lett; 1999 Mar; 262(2):129-32. PubMed ID: 10203248
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Role of PPAR-gamma ligands in neuroprotection against glutamate-induced cytotoxicity in retinal ganglion cells.
    Aoun P; Simpkins JW; Agarwal N
    Invest Ophthalmol Vis Sci; 2003 Jul; 44(7):2999-3004. PubMed ID: 12824244
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Characteristics of the peroxisome proliferator activated receptor gamma (PPARgamma) ligand induced apoptosis in colon cancer cells.
    Shimada T; Kojima K; Yoshiura K; Hiraishi H; Terano A
    Gut; 2002 May; 50(5):658-64. PubMed ID: 11950812
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Prostaglandin-J2 induces synthesis of interleukin-8 by endothelial cells in a PPAR-gamma-independent manner.
    Jozkowicz A; Dulak J; Prager M; Nanobashvili J; Nigisch A; Winter B; Weigel G; Huk I
    Prostaglandins Other Lipid Mediat; 2001 Oct; 66(3):165-77. PubMed ID: 11577781
    [TBL] [Abstract][Full Text] [Related]  

  • 36. 15-deoxy-Δ(12,14) -prostaglandin-J2 and ciglitazone inhibit TNF-α-induced matrix metalloproteinase 13 production via the antagonism of NF-κB activation in human synovial fibroblasts.
    Lin TH; Tang CH; Wu K; Fong YC; Yang RS; Fu WM
    J Cell Physiol; 2011 Dec; 226(12):3242-50. PubMed ID: 21344384
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Peroxisome proliferator-activated receptor gamma transcriptional regulation is involved in platelet-derived growth factor-induced proliferation of human hepatic stellate cells.
    Galli A; Crabb D; Price D; Ceni E; Salzano R; Surrenti C; Casini A
    Hepatology; 2000 Jan; 31(1):101-8. PubMed ID: 10613734
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Differential regulation of chemokine gene expression by 15-deoxy-delta 12,14 prostaglandin J2.
    Zhang X; Wang JM; Gong WH; Mukaida N; Young HA
    J Immunol; 2001 Jun; 166(12):7104-11. PubMed ID: 11390455
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Peroxisome proliferator activator receptor-gamma ligands, 15-deoxy-Delta(12,14)-prostaglandin J2 and ciglitazone, reduce systemic inflammation in polymicrobial sepsis by modulation of signal transduction pathways.
    Zingarelli B; Sheehan M; Hake PW; O'Connor M; Denenberg A; Cook JA
    J Immunol; 2003 Dec; 171(12):6827-37. PubMed ID: 14662889
    [TBL] [Abstract][Full Text] [Related]  

  • 40. 15-deoxy-delta12,14-prostaglandin J2 regulates the functional state and the survival of microglial cells through multiple molecular mechanisms.
    Bernardo A; Ajmone-Cat MA; Levi G; Minghetti L
    J Neurochem; 2003 Nov; 87(3):742-51. PubMed ID: 14535956
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.